BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 26190088)

  • 1. Heavy Cigarette Smoking and Aggressive Bladder Cancer at Initial Presentation.
    Pietzak EJ; Mucksavage P; Guzzo TJ; Malkowicz SB
    Urology; 2015 Nov; 86(5):968-72. PubMed ID: 26190088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of smoking status on bladder tumor recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.
    Hagiwara M; Kikuchi E; Tanaka N; Matsumoto K; Ide H; Miyajima A; Masuda T; Nakamura S; Oya M
    J Urol; 2013 Jun; 189(6):2062-8. PubMed ID: 23328579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.
    Rink M; Zabor EC; Furberg H; Xylinas E; Ehdaie B; Novara G; Babjuk M; Pycha A; Lotan Y; Trinh QD; Chun FK; Lee RK; Karakiewicz PI; Fisch M; Robinson BD; Scherr DS; Shariat SF
    Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of smoking status and cumulative smoking exposure on tumor recurrence of non-muscle-invasive bladder cancer.
    Li HM; Azhati B; Rexiati M; Wang WG; Li XD; Liu Q; Wang YJ
    Int Urol Nephrol; 2017 Jan; 49(1):69-76. PubMed ID: 27766490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical-pathological differences and smoking habit depending on gender in a cohort of patients with transitional cell carcinoma of the bladder: retrospective study.
    Lorente JA; Bielsa O; Rijo E; Cortadellas R; Nohales G; Francés A; Juanpere N; Lloreta J; Arango O
    Arch Esp Urol; 2011 Jun; 64(5):427-33. PubMed ID: 21705815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cigarette smoking and drinking water source: correlation with clinical features and pathology of superficial bladder carcinoma.
    Serretta V; Altieri V; Morgia G; Allegro R; Ruggirello A; Di Lallo A; Carrieri G; Melloni D;
    Urol Int; 2009; 82(3):318-23. PubMed ID: 19440021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender.
    Samanic C; Kogevinas M; Dosemeci M; Malats N; Real FX; Garcia-Closas M; Serra C; Carrato A; García-Closas R; Sala M; Lloreta J; Tardón A; Rothman N; Silverman DT
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1348-54. PubMed ID: 16835335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens.
    Wallerand H; Bakkar AA; de Medina SG; Pairon JC; Yang YC; Vordos D; Bittard H; Fauconnet S; Kouyoumdjian JC; Jaurand MC; Zhang ZF; Radvanyi F; Thiery JP; Chopin DK
    Carcinogenesis; 2005 Jan; 26(1):177-84. PubMed ID: 15347601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification.
    Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI
    J Urol; 2005 Nov; 174(5):1976-80. PubMed ID: 16217372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Kim KH; You D; Jeong IG; Hong JH; Ahn H; Kim CS
    Urol Oncol; 2013 Nov; 31(8):1643-9. PubMed ID: 22591745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A molecular and epidemiological study on bladder cancer: p53 mutations, tobacco smoking, and occupational exposure to asbestos.
    Kannio A; Ridanpää M; Koskinen H; Partanen T; Anttila S; Collan Y; Hietanen E; Vainio H; Husgafvel-Pursiainen K
    Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):33-9. PubMed ID: 8770464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in bladder cancer outcomes among smokers with advanced bladder cancer.
    Boström PJ; Alkhateeb S; Trottier G; Athanasopoulos PZ; Mirtti T; Kortekangas H; Laato M; van Rhijn B; van der Kwast T; Fleshner NE; Jewett MA; Finelli A; Zlotta AR
    BJU Int; 2012 Jan; 109(1):70-6. PubMed ID: 21851540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple adverse histological features increase the odds of under staging T1 bladder cancer.
    Weizer AZ; Wasco MJ; Wang R; Daignault S; Lee CT; Shah RB
    J Urol; 2009 Jul; 182(1):59-65; discussion 65. PubMed ID: 19447443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking and timing of cessation: impact on pulmonary complications after thoracotomy.
    Barrera R; Shi W; Amar D; Thaler HT; Gabovich N; Bains MS; White DA
    Chest; 2005 Jun; 127(6):1977-83. PubMed ID: 15947310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.
    Wright JL; Black PC; Brown GA; Porter MP; Kamat AM; Dinney CP; Lin DW
    J Urol; 2007 Dec; 178(6):2302-6; discussion 2307. PubMed ID: 17936803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder cancer in Sri Lanka: experience from a tertiary referral center.
    Goonewardena SA; De Silva WA; De Silva MV
    Int J Urol; 2004 Nov; 11(11):969-72. PubMed ID: 15509199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration and intensity of tobacco smoking and the risk of papillary and non-papillary transitional cell carcinoma of the bladder.
    Polesel J; Bosetti C; di Maso M; Montella M; Libra M; Garbeglio A; Zucchetto A; Turati F; Talamini R; La Vecchia C; Serraino D
    Cancer Causes Control; 2014 Sep; 25(9):1151-8. PubMed ID: 24964779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking Cessation and the Risk of Bladder Cancer among Postmenopausal Women.
    Li Y; Tindle HA; Hendryx MS; Xun P; He K; Liang X; Luo J
    Cancer Prev Res (Phila); 2019 May; 12(5):305-314. PubMed ID: 31043379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
    David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.